Poland· PL-100450370
Tadomon
A tapentadol product containing tapentadolum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tapentadol is registered in 17 of 19 countries.
Countries holding a registration under ATC N02AX06 (tapentadol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Tapentadol · ATC N02AX06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tapentadol costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $2.14 in Italy to $6.62 in Switzerland — a ×3.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tapentadol · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.62
- ES Spain$3.34
- IT Italy$2.14
The record
At a glance
URPL (Poland)- Active substance
- Tapentadolum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N02AX06
- ATC class
- Tapentadol
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 12
1 priced- gtin0900873201745860 szt.PLN 43.09
- gtin09008732017410
- gtin09008732017434
- gtin09008732017427
- gtin08436046015333
- gtin08436046015210
- gtin08436046015159
- gtin08436046015272
- gtin08436046015395
- gtin05909991535193
- gtin09008732017441
- gtin09008732017465
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
184 interactions on record for tapentadol.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tapentadol · interactions on record
184 records
- 30 severe
- 130 moderate
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tapentadol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTABOXEAG.L. Pharma GmbH, Lannach
- SpainPALEXIA RETARD 25 mg COMPRIMIDOS DE LIBERACION PROLONGADAGrünenthal Pharma S.A.
- SwedenPalexia Depot 25 mg DepottablettGrünenthal GmbH
- NetherlandsPalexia Retard 25 mg, tabletten met verlengde afgifteGrünenthal B.V.
- IrelandPALEXIA SR 25 mg prolonged-release tabletsGrunenthal Pharma Limited.
- BelgiumPalexia Retard 25 mgGrunenthal
- ItalyPALEXIAGRUNENTHAL ITALIA S.R.L.
- FinlandPalexia DepotGrünenthal GmbH
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Palexia, Palexia Retard
- Belgium · Palexia, Palexia Retard
- Cyprus · Dolten, Dolten Retard
- Czechia · Apeneta, Dolupren
- Germany · Palexia, Palexia Akutschmerz
- Denmark · Palexia, Palexia Depot
- Estonia · Tapemed Retard
- Spain · Palexia, Palexia Retard
- United Kingdom (Northern Ireland) · Ationdo, Ationdo Sr
- Greece · Dolupren, Dolupren Ir
- Croatia · Apeneta, Dolten
- Hungary · Adoben
- Ireland · Apeneta, Palexia
- Iceland · Tapentadol Stada
- Italy · Palexia, Taboxea
- Luxembourg · Palexia, Palexia Retard
- Malta · Dolten, Dolten Retard
- Netherlands · Palexia, Palexia Retard
- Norway · Palexia, Palexia Depot
- Portugal · Ationdo, Palexia
- Romania · Dolten
- Sweden · Palexia, Palexia Depot
- Slovenia · Apeneta, Palexia
- Slovakia · Apeneta, Dolten
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfc2b2fc-1058-4595-b4d5-d3dec9446e5a GET /v1/drugs/dfc2b2fc-1058-4595-b4d5-d3dec9446e5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki o przedłużonym uwalnianiu",
"source": "urpl",
"strength": "25 mg",
"packaging": "08436046015333 ¦ Rpw ¦ Skasowane ¦ 146768\n60 tabl.\n08436046015210 ¦ Rpw ¦ Skasowane ¦ 146769\n28 tabl.\n08436046015159 ¦ Rpw ¦ Skasowane ¦ 146770\n7 tabl.\n08436046015272 ¦ Rpw ¦ Skasowane ¦ 146771\n30 tabl.\n08436046015395 ¦ Rpw ¦ Skasowane ¦ 146772\n100 tabl.\n05909991535193 ¦ Rpw ¦ Skasowane ¦ 153766\n40 tabl.\n09008732017441 ¦ Rpw ¦ 156959\n40 tabl.\n09008732017465 ¦ Rpw ¦ 156960\n100 tabl.\n09008732017410 ¦ Rpw ¦ 156961\n7 tabl.\n09008732017434 ¦ Rpw ¦ 156962\n30 tabl.\n09008732017458 ¦ Rpw ¦ 156963\n60 tabl.\n09008732017427 ¦ Rpw ¦ 156964\n28 tabl.",
"substance": "Tapentadoli tartras 41.9525 mg",
"common_name": "Tapentadolum",
"pl_product_id": "100450370",
"pozwolenie_nr": "27335",
"auth_procedure": "DCP",
"authorisation_validity": "2027-09-07"
}See everything about tapentadol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.